Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia
- Que, Y.-A et al
- swissbib.ch:(NATIONALLICENCE)springer-10.1007/s10096-014-2156-1
Main file(s):
| Restricted | |||||||
 10096_2014_Article_2156
|
|||||||
| version 1 |
| ||||||
